Cells,
Год журнала:
2022,
Номер
11(13), С. 2091 - 2091
Опубликована: Июнь 30, 2022
Neuroinflammation
is
a
hallmark
of
many
neurodegenerative
diseases
(NDs)
and
plays
fundamental
role
in
mediating
the
onset
progression
disease.
Microglia,
which
function
as
first-line
immune
guardians
central
nervous
system
(CNS),
are
drivers
neuroinflammation.
Numerous
human
postmortem
studies
vivo
imaging
analyses
have
shown
chronically
activated
microglia
patients
with
various
acute
chronic
neuropathological
diseases.
While
microglial
activation
common
feature
NDs,
exact
pathological
states
complex
often
contradictory.
However,
there
consensus
that
play
biphasic
conditions,
detrimental
protective
phenotypes,
overall
response
different
phenotypes
depends
on
nature
duration
inflammatory
insult,
well
stage
disease
development.
This
review
provides
comprehensive
overview
current
research
responses
health,
aging,
special
emphasis
heterogeneous
phenotypic
such
hemorrhagic
stroke
(HS),
Alzheimer's
(AD),
Parkinson's
(PD).
The
primary
focus
translational
preclinical
animal
models
bulk/single-cell
transcriptome
samples.
Additionally,
this
covers
key
receptors
signaling
pathways
potential
therapeutic
targets
to
regulate
during
aging
NDs.
age-,
sex-,
species-specific
differences
will
be
briefly
reviewed.
Cell Research,
Год журнала:
2020,
Номер
30(6), С. 492 - 506
Опубликована: Май 20, 2020
Abstract
The
interplay
between
the
commensal
microbiota
and
mammalian
immune
system
development
function
includes
multifold
interactions
in
homeostasis
disease.
microbiome
plays
critical
roles
training
of
major
components
host’s
innate
adaptive
system,
while
orchestrates
maintenance
key
features
host-microbe
symbiosis.
In
a
genetically
susceptible
host,
imbalances
microbiota-immunity
under
defined
environmental
contexts
are
believed
to
contribute
pathogenesis
multitude
immune-mediated
disorders.
Here,
we
review
microbiome-immunity
crosstalk
their
health
disease,
providing
examples
molecular
mechanisms
orchestrating
these
intestine
extra-intestinal
organs.
We
highlight
aspects
current
knowledge,
challenges
limitations
achieving
causal
understanding
host
immune-microbiome
interactions,
as
well
impact
on
diseases,
discuss
how
insights
may
translate
towards
future
microbiome-targeted
therapeutic
interventions.
Frontiers in Cellular Neuroscience,
Год журнала:
2020,
Номер
14
Опубликована: Авг. 6, 2020
Inflammatory
processes
and
microglia
activation
accompanies
most
of
the
pathophysiological
diseases
in
central
nervous
system.
It
is
proven
that
glial
pathology
precedes
even
drives
development
multiple
neurodegenerative
conditions.
A
growing
number
studies
point
out
importance
brain
as
well
physiological
functioning.
Those
resident
immune
cells
are
divergent
from
peripherally
infiltrated
macrophages,
but
their
precise
situ
discrimination
surprisingly
difficult.
Microglia
heterogeneity
visible
especially
morphology,
cell
density
particular
structures,
also
expression
cellular
markers.
This
often
determines
role
physiology
or
The
species
differences
between
rodent
human
markers
add
complexity
to
whole
picture.
Furthermore,
due
activation,
shows
a
broad
spectrum
phenotypes
ranging
pro-inflammatory,
potentially
cytotoxic
M1,
anti-inflammatory,
scavenging
regenerative
M2.
distinction
specific
nowadays
essential
study
microglial
functions
tissue
state
such
quickly
changing
environment.
Due
overwhelming
data
on
sets
available
for
studies,
choice
appropriate
scientific
challenge.
review
gathers,
classifies
describes
known
recently
discovered
protein
expressed
by
different
phenotypes.
Presented
include
qualitative
semi-quantitative,
general
specific,
surface
intracellular
proteins
secreted
molecules.
Information
provided
here
creates
comprehensive
practical
guide
trough
current
knowledge
will
allow
choose
proper,
more
detailed
neuroinflammatory
mechanisms
various,
physiological,
pathological,
Both,
basic
research
clinical
medicine,
need
clearly
described
validated
molecular
phenotype,
diagnostics,
treatment
prevention
engaging
glia
activation.
Cell Reports,
Год журнала:
2020,
Номер
30(5), С. 1271 - 1281
Опубликована: Фев. 1, 2020
Microglia
are
resident
immune
cells
in
the
central
nervous
system
(CNS)
that
capable
of
carrying
out
prominent
and
various
functions
during
development
adulthood
under
both
homeostatic
disease
conditions.
Although
microglia
traditionally
thought
to
be
heterogeneous
populations,
which
potentially
allows
them
achieve
a
wide
range
responses
environmental
changes
for
maintenance
CNS
homeostasis,
lack
unbiased
high-throughput
methods
assess
heterogeneity
has
prevented
study
spatially
temporally
distributed
subsets.
The
recent
emergence
novel
single-cell
techniques,
such
as
cytometry
by
time-of-flight
mass
spectrometry
(CyTOF)
RNA
sequencing,
enabled
scientists
overcome
limitations
reveal
surprising
context-dependent
microglia.
In
this
review,
we
summarize
current
knowledge
about
spatial,
temporal,
functional
diversity
development,
mice
humans.
Psychiatry and Clinical Neurosciences,
Год журнала:
2019,
Номер
73(4), С. 143 - 153
Опубликована: Янв. 17, 2019
While
post-traumatic
stress
disorder
(PTSD)
is
currently
diagnosed
based
solely
on
classic
psychological
and
behavioral
symptoms,
a
growing
body
of
evidence
has
highlighted
link
between
this
alterations
in
the
immune
inflammatory
systems.
Epidemiological
studies
have
demonstrated
that
PTSD
associated
with
significantly
increased
rates
physical
comorbidities
which
dysregulation
involved,
such
as
metabolic
syndrome,
atherosclerotic
cardiovascular
disease,
autoimmune
diseases.
In
line
this,
number
blood
biomarker
reported
compared
to
healthy
controls,
individuals
exhibit
elevated
levels
proinflammatory
markers,
interleukin-1β,
interleukin-6,
tumor
necrosis
factor-α,
C-reactive
protein.
Moreover,
various
lines
animal
human
research
suggested
inflammation
not
only
but
also
can
play
an
important
role
its
pathogenesis
pathophysiology.
review,
we
first
summarize
suggestive
PTSD.
We
then
examine
findings
suggest
possible
mechanisms
terms
two
different
interrelated
perspectives:
putative
causes
activities
potential
consequences
generates.
Given
there
dearth
treatment
options
for
PTSD,
possibilities
new
therapeutic
approaches
using
pharmacological
non-pharmacological
treatments/interventions
anti-inflammatory
effects
are
discussed.
Despite
increasing
attention
given
pathology
remains
much
be
elucidated,
including
more
detailed
inflammation,
usefulness
biomarkers
diagnostic
prognostic
efficacy
novel
strategies
targeting
inflammation.